000 01656 a2200493 4500
005 20250514073117.0
264 0 _c20030829
008 200308s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.2003.tb03167.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMolinoff, P B
245 0 0 _aPT-141: a melanocortin agonist for the treatment of sexual dysfunction.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cJun 2003
300 _a96-102 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdministration, Intranasal
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aErectile Dysfunction
_xdrug therapy
650 0 4 _aGenes, fos
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeurons
_xcytology
650 0 4 _aParaventricular Hypothalamic Nucleus
_xcytology
650 0 4 _aPenile Erection
650 0 4 _aPeptides, Cyclic
_xmetabolism
650 0 4 _aPhotic Stimulation
650 0 4 _aPlacebos
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptor, Melanocortin, Type 3
650 0 4 _aReceptor, Melanocortin, Type 4
650 0 4 _aReceptors, Corticotropin
_xgenetics
650 0 4 _aalpha-MSH
_xanalogs & derivatives
700 1 _aShadiack, A M
700 1 _aEarle, D
700 1 _aDiamond, L E
700 1 _aQuon, C Y
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 994
_gp. 96-102
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.2003.tb03167.x
_zAvailable from publisher's website
999 _c12631916
_d12631916